Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
InGeneron
AddedFeb 15, 2024
UpdatedJun 18, 2026
InGeneron

InGeneron

Series D

InGeneron: A multinational biotech firm unlocking patient healing through innovative regenerative therapies.

HQ
Houston, TX, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

InGeneron, founded in 2006 and headquartered in Houston, Texas, is a multinational biotechnology company focused on developing innovative regenerative therapies. The company's mission is to unlock the healing potential of each patient's own regenerative cells through novel, safe, and evidence-based treatments. InGeneron offers products and services in regenerative cell separation and diagnostic tools, targeting markets in wound care, aesthetics & reconstruction, orthopedics & spine, cardiovascular, and animal health. The company serves regions including the USA, Europe, and the Middle East.

Notable figures associated with InGeneron include founder and Chairman of the Board Eckhard Alt, CEO Angelo Moesslang, and President Ron Stubbers. The company has achieved significant milestones in cell therapy and stem cell research over its 16 years of operation. With subsidiaries like InGeneron GmbH and InGene, InGeneron has made impactful contributions to the biotechnology field, particularly in enhancing patient care through advanced regenerative medicine solutions.

InGeneron - Similar Companies

Endogena Therapeutics logo

Endogena Therapeutics

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

Histogen logo

Histogen

histogen.com

Spheringenics logo

Spheringenics

DiscGenics logo

DiscGenics

discgenics.com

SironRX Therapeutics logo

SironRX Therapeutics

sironrx.com

BioRegenx logo

BioRegenx

bioregenx.com

iReprogram logo

iReprogram

ireprogram.com

Caeregen Therapeutics logo

Caeregen Therapeutics

caeregen.com

Regenxbio logo

Regenxbio

regenxbio.com

Regenerative Medical Solutions logo

Regenerative Medical Solutions

Ventrinova logo

Ventrinova

Longeveron logo

Longeveron

longeveron.com

GentiBio logo

GentiBio

gentibio.com

Stemgenics logo

Stemgenics

stemgenics.com

InGeneron - Quick Facts

Who are InGeneron's competitors?

Companies similar to InGeneron include Endogena Therapeutics, Juventas Therapeutics, Histogen and Spheringenics.

When was InGeneron founded?

InGeneron was founded in 2006.

Where is InGeneron's headquarters located?

InGeneron's headquarters is located in Houston, TX, US.

When was InGeneron's last funding round?

InGeneron's most recent funding round was for $23M (USD) in June 2019.

How much has InGeneron raised to-date?

As of Jun 11, 2019, InGeneron has raised a total of $51M (USD).

How many employees does InGeneron have?

InGeneron has 32 employees as of Feb 5, 2024.

InGeneron - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Regenerative Therapies
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 21 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 339990All Other Miscellaneous Manufacturing
  • 339999All Other Miscellaneous Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 339000Miscellaneous Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 339900Other Miscellaneous Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3990Miscellaneous Manufacturing Industries
  • 3999Manufacturing Industries, Not Elsewhere Classified
  • 2800Chemicals And Allied Products
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified